Antioxidant Properties of Kynurenines: Density Functional Theory Calculations

Kynurenines, the main products of tryptophan catabolism, possess both prooxidant and anioxidant effects. Having multiple neuroactive properties, kynurenines are implicated in the development of neurological and cognitive disorders, such as Alzheimer's, Parkinson's, and Huntington's diseases. Autoxidation of 3-hydroxykynurenine (3HOK) and its derivatives, 3-hydroxyanthranilic acid (3HAA) and xanthommatin (XAN), leads to the hyperproduction of reactive oxygen species (ROS) which damage cell structures. At the same time, 3HOK and 3HAA have been shown to be powerful ROS scavengers. Their ability to quench free radicals is believed to result from the presence of the aromatic hydroxyl group which is able to easily abstract an electron and H-atom. In this study, the redox properties for kynurenines and several natural and synthetic antioxidants have been calculated at different levels of density functional theory in the gas phase and water solution. Hydroxyl bond dissociation enthalpy (BDE) and ionization potential (IP) for 3HOK and 3HAA appear to be lower than for xanthurenic acid (XAA), several phenolic antioxidants, and ascorbic acid. BDE and IP for the compounds with aromatic hydroxyl group are lower than for their precursors without hydroxyl group. The reaction rate for H donation to *O-atom of phenoxyl radical (Ph-O*) and methyl peroxy radical (Met-OO*) decreases in the following rankings: 3HOK ~ 3HAA > XAAOXO > XAAENOL. The enthalpy absolute value for Met-OO* addition to the aromatic ring of the antioxidant radical increases in the following rankings: 3HAA* < 3HOK* < XAAOXO* < XAAENOL*. Thus, the high free radical scavenging activity of 3HAA and 3HOK can be explained by the easiness of H-atom abstraction and transfer to O-atom of the free radical, rather than by Met-OO* addition to the kynurenine radical.

[1]  Annia Galano,et al.  A computational methodology for accurate predictions of rate constants in solution: Application to the assessment of primary antioxidant activity , 2013, J. Comput. Chem..

[2]  J. M. Simoes,et al.  Energetics of the O–H Bond in Phenol and Substituted Phenols: A Critical Evaluation of Literature Data , 1998 .

[3]  R. Schwarcz,et al.  Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid , 1984, Neuroscience Letters.

[4]  H. Szymusiak,et al.  BOND DISSOCIATION ENTHALPY OF PHENOLIC ANTIOXIDANTS , 2003 .

[5]  N. Nishiyama,et al.  3‐Hydroxykynurenine, an Endogenous Oxidative Stress Generator, Causes Neuronal Cell Death with Apoptotic Features and Region Selectivity , 1998, Journal of neurochemistry.

[6]  C. Jacob,et al.  Electrochemical and in vitro evaluation of the redox-properties of kynurenine species. , 2003, Biochemical and biophysical research communications.

[7]  N. Russo,et al.  Density functional study of the antioxidant activity of some recently synthesized resveratrol analogues. , 2013, Food chemistry.

[8]  Yuan-zong Li,et al.  Study on the multiple mechanisms underlying the reaction between hydroxyl radical and phenolic compounds by qualitative structure and activity relationship. , 2002, Bioorganic & medicinal chemistry.

[9]  L. Valgimigli,et al.  Substituent effects on the bond dissociation enthalpies of aromatic amines. , 2002, Journal of the American Chemical Society.

[10]  R. Beninger,et al.  The neurotoxic actions of quinolinic acid in the central nervous system. , 1986, Canadian journal of physiology and pharmacology.

[11]  Harris Simplified method for calculating the energy of weakly interacting fragments. , 1985, Physical review. B, Condensed matter.

[12]  J. Pople,et al.  Self‐consistent molecular orbital methods. XX. A basis set for correlated wave functions , 1980 .

[13]  R. Schwarcz,et al.  Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism , 1991, Journal of neurochemistry.

[14]  R. Stocker,et al.  Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Pedraza-Chaverri,et al.  Kynurenines with Neuroactive and Redox Properties: Relevance to Aging and Brain Diseases , 2014, Oxidative medicine and cellular longevity.

[16]  L. Reneker,et al.  Indoleamine 2,3-dioxygenase overexpression causes kynurenine-modification of proteins, fiber cell apoptosis and cataract formation in the mouse lens , 2009, Laboratory Investigation.

[17]  R. Stocker,et al.  3-Hydroxyanthranilic Acid Is an Efficient, Cell-derived Co-antioxidant for α-Tocopherol, Inhibiting Human Low Density Lipoprotein and Plasma Lipid Peroxidation* , 1996, The Journal of Biological Chemistry.

[18]  M. Heisenberg,et al.  Age-dependent memory loss, synaptic pathology and altered brain plasticity in the Drosophila mutant cardinal accumulating 3-hydroxykynurenine , 2000, Journal of Neural Transmission.

[19]  Weston Thatcher Borden,et al.  Proton-coupled electron transfer versus hydrogen atom transfer in benzyl/toluene, methoxyl/methanol, and phenoxyl/phenol self-exchange reactions. , 2002, Journal of the American Chemical Society.

[20]  R. Truscott,et al.  Characterisation of the major autoxidation products of 3-hydroxykynurenine under physiological conditions , 2000, Free radical research.

[21]  C. Alves,et al.  A theoretical study of phenolic compounds with antioxidant properties. , 2007, European journal of medicinal chemistry.

[22]  Delano P. Chong,et al.  Interpretation of the Kohn-Sham orbital energies as approximate vertical ionization potentials , 2002 .

[23]  Alessandro Pedretti,et al.  VEGA – An open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming , 2004, J. Comput. Aided Mol. Des..

[24]  W. Goddard,et al.  Doubly hybrid density functional for accurate descriptions of nonbond interactions, thermochemistry, and thermochemical kinetics , 2009, Proceedings of the National Academy of Sciences.

[25]  Wolfgang Brandt,et al.  Virtual screening for plant PARP inhibitors – what can be learned from human PARP inhibitors? , 2012, Journal of Cheminformatics.

[26]  A. James,et al.  Oxidation of 3-hydroxykynurenine to produce xanthommatin for eye pigmentation: a major branch pathway of tryptophan catabolism during pupal development in the yellow fever mosquito, Aedes aegypti. , 1999, Insect biochemistry and molecular biology.

[27]  M. Torres-Ramos,et al.  On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress. , 2011, Neurotoxicology and teratology.

[28]  Denis M. Bayada,et al.  Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs , 1999, Pharmaceutical Research.

[29]  A. D. da Silva,et al.  Density Functional Theory (DFT) Study of Edaravone Derivatives as Antioxidants , 2012, International journal of molecular sciences.

[30]  R. Schwarcz,et al.  Kynurenines in the mammalian brain: when physiology meets pathology , 2012, Nature Reviews Neuroscience.

[31]  R. Kido,et al.  Superoxide dismutase enhances the formation of hydroxyl radicals in the reaction of 3-hydroxyanthranilic acid with molecular oxygen. , 1988, The Biochemical journal.

[32]  G. Leipnitz,et al.  In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain , 2007, Neurochemistry International.

[33]  Marcus D. Hanwell,et al.  Avogadro: an advanced semantic chemical editor, visualization, and analysis platform , 2012, Journal of Cheminformatics.

[34]  H. Luk,et al.  Thermodynamic and kinetic study of ibuprofen with hydroxyl radical: A density functional theory approach , 2014 .

[35]  Patrick Marroum,et al.  Mechanistic analysis of solute transport in an in vitro physiological two‐phase dissolution apparatus , 2012 .

[36]  Yu-ran Luo,et al.  Comprehensive handbook of chemical bond energies , 2007 .

[37]  Ian J. Rhile,et al.  Thermodynamics and kinetics of proton-coupled electron transfer: stepwise vs. concerted pathways. , 2004, Biochimica et biophysica acta.

[38]  J. Haavik,et al.  Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case–control study , 2015, Behavioral and Brain Functions.

[39]  Leeor Kronik,et al.  Excitation Gaps of Finite-Sized Systems from Optimally Tuned Range-Separated Hybrid Functionals. , 2012, Journal of chemical theory and computation.

[40]  S. Burton,et al.  Phenoxazinone synthase: what's in a name? , 2009, Trends in biotechnology.

[41]  J. Pedraza-Chaverri,et al.  The Janus faces of 3-hydroxykynurenine: Dual redox modulatory activity and lack of neurotoxicity in the rat striatum , 2014, Brain Research.

[42]  R. Schwarcz,et al.  Drosophila eye color mutants as therapeutic tools for Huntington disease , 2012, Fly.

[43]  S. F. Boys,et al.  The calculation of small molecular interactions by the differences of separate total energies. Some procedures with reduced errors , 1970 .

[44]  A. Daniel Boese,et al.  A new parametrization of exchange–correlation generalized gradient approximation functionals , 2001 .

[45]  Tjerk P. Straatsma,et al.  NWChem: A comprehensive and scalable open-source solution for large scale molecular simulations , 2010, Comput. Phys. Commun..

[46]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[47]  Benedetta Mennucci,et al.  Polarizable continuum model , 2012 .

[48]  N. Nishiyama,et al.  Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[49]  R. Mannhold,et al.  Calculation of molecular lipophilicity: state of the art and comparison of methods on more than 96000 compounds , 2009, Journal of pharmaceutical sciences.

[50]  Mark S. Gordon,et al.  General atomic and molecular electronic structure system , 1993, J. Comput. Chem..

[51]  G. Lynch,et al.  A Glycine Site Associated with N‐Methyl‐d‐Aspartic Acid Receptors: Characterization and Identification of a New Class of Antagonists , 1989, Journal of neurochemistry.

[52]  Parr,et al.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. , 1988, Physical review. B, Condensed matter.

[53]  Paolo Guidetti,et al.  A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease , 2005, Nature Genetics.

[54]  A. Hoeflich,et al.  Endotoxin-Induced Tryptophan Degradation along the Kynurenine Pathway: The Role of Indolamine 2,3-Dioxygenase and Aryl Hydrocarbon Receptor-Mediated Immunosuppressive Effects in Endotoxin Tolerance and Cancer and Its Implications for Immunoparalysis , 2015, Journal of amino acids.

[55]  A. Stern,et al.  Oxidative reactivity of the tryptophan metabolites 3-hydroxyanthranilate, cinnabarinate, quinolinate and picolinate. , 1987, Biochemical pharmacology.

[56]  J. Phillips,et al.  Terminal synthesis of xanthommatin in Drosophila melanogaster. 3. Mutational pleiotropy and pigment granule association of phenoxazinone synthetase. , 1973, Genetics.

[57]  Giovanni Messina,et al.  Short-Term Diet and Moderate Exercise in Young Overweight Men Modulate Cardiocyte and Hepatocarcinoma Survival by Oxidative Stress , 2014, Oxidative medicine and cellular longevity.

[58]  R. Schwarcz,et al.  Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities , 2002, Journal of Pharmacology and Experimental Therapeutics.

[59]  K. Murakami,et al.  Xanthurenic acid inhibits metal ion-induced lipid peroxidation and protects NADP-isocitrate dehydrogenase from oxidative inactivation. , 2001, Journal of nutritional science and vitaminology.

[60]  G. Oxenkrug,et al.  Elevated anthranilic acid plasma concentrations in type 1 but not type 2 diabetes mellitus. , 2015, Integrative molecular medicine.

[61]  R. Kido,et al.  Formation of hydroxanthommatin-derived radical in the oxidation of 3-hydroxykynurenine. , 1992, Archives of biochemistry and biophysics.

[62]  M. Lucarini,et al.  Determination of the substituent effect on the O-H bond dissociation enthalpies of phenolic antioxidants by the EPR radical equilibration technique. , 2002, The Journal of organic chemistry.

[63]  L. Valgimigli,et al.  Kinetic and thermodynamic aspects of the chain-breaking antioxidant activity of ascorbic acid derivatives in non-aqueous media. , 2011, Organic & biomolecular chemistry.

[64]  Increased Plasma Levels of Xanthurenic and Kynurenic Acids in Type 2 Diabetes , 2015, Molecular Neurobiology.

[65]  K. Morokuma,et al.  Intrinsic reaction coordinate: Calculation, bifurcation, and automated search , 2015 .

[66]  Hong-yu Zhang,et al.  Electronic effects on O-H proton dissociation energies of phenolic cation radicals: a DFT study. , 2002, Journal of Organic Chemistry.

[67]  M. Foti Antioxidant properties of phenols , 2007, The Journal of pharmacy and pharmacology.

[68]  R. Stocker,et al.  Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway. , 1994, The Journal of clinical investigation.

[69]  P. Selzer,et al.  Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.

[70]  H. Korth,et al.  Why Quantum-Thermochemical Calculations Must Be Used with Caution to Indicate ‘a Promising Lead Antioxidant’ , 2005 .

[71]  Bryan M. Wong,et al.  Nonempirically Tuned Range-Separated DFT Accurately Predicts Both Fundamental and Excitation Gaps in DNA and RNA Nucleobases , 2012, Journal of chemical theory and computation.

[72]  K. Nikolić Theoretical study of phenolic antioxidants properties in reaction with oxygen-centered radicals , 2006 .

[73]  J. Gomes,et al.  Density functional theory study on the thermodynamic properties of aminophenols , 2005 .

[74]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[75]  I. Pajeva,et al.  Computational Studies of Free Radical-Scavenging Properties of Phenolic Compounds. , 2014, Current topics in medicinal chemistry.

[76]  R. Stocker,et al.  Simultaneous determination of 3-hydroxyanthranilic and cinnabarinic acid by high-performance liquid chromatography with photometric or electrochemical detection. , 1992, Analytical biochemistry.

[77]  Jerzy Leszczynski,et al.  MaSK: A visualization tool for teaching and research in computational chemistry , 2009 .

[78]  L. Chylack,et al.  3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction. , 2000, Biochemistry.

[79]  F. Hadacek,et al.  Quinolinic Acid: Neurotoxin or Oxidative Stress Modulator? , 2013, International journal of molecular sciences.

[80]  Jin-Tai Yu,et al.  The kynurenine pathway in neurodegenerative diseases: Mechanistic and therapeutic considerations , 2012, Journal of the Neurological Sciences.

[81]  J. Gostner,et al.  Antioxidants, inflammation and cardiovascular disease. , 2014, World journal of cardiology.

[82]  P. C. Hariharan,et al.  The influence of polarization functions on molecular orbital hydrogenation energies , 1973 .